Vascular cell adhesion molecule 1 in patients with severe osteoarthritis of the hip

[1]  E. Roughead,et al.  Prevalence and changes in analgesic medication utilisation 1 year prior to total joint replacement in an older cohort of patients. , 2017, Osteoarthritis and cartilage.

[2]  A. Stadlmayr,et al.  Cardiovascular Risk and Known Coronary Artery Disease Are Associated With Colorectal Adenoma and Advanced Neoplasia. , 2017, Journal of the American College of Cardiology.

[3]  A. Engin.  Endothelial Dysfunction in Obesity. , 2017, Advances in experimental medicine and biology.

[4]  Pei-Chin Lin,et al.  Soluble vascular cell adhesion molecular-1 is a potential biological indicator of hemophilic arthropathy , 2016, Medicine.

[5]  C. Louy,et al.  Perioperative factors associated with Hospital Consumer Assessment of Healthcare Providers and Systems responses of total hip arthroplasty patients. , 2016, Journal of clinical anesthesia.

[6]  Z. Zha,et al.  Metabolic Syndrome Increases the Risk for Knee Osteoarthritis: A Meta-Analysis , 2016, Evidence-based complementary and alternative medicine : eCAM.

[7]  D. Hunter,et al.  Hip Osteoarthritis: Etiopathogenesis and Implications for Management , 2016, Advances in Therapy.

[8]  J. Norrie,et al.  Pragmatic Trials. , 2016, The New England journal of medicine.

[9]  O. Franco,et al.  Markers of atherosclerosis in relation to presence and progression of knee osteoarthritis: a population-based cohort study. , 2015, Rheumatology.

[10]  N. Arden,et al.  Assessing risk factors for early hip osteoarthritis in activity-related hip pain: a Delphi study , 2015, BMJ Open.

[11]  F. Berenbaum,et al.  Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis , 2015, RMD Open.

[12]  A. Stadlmayr,et al.  VCAM-1 serum levels are associated with arthropathy in hereditary haemochromatosis , 2013, Annals of the rheumatic diseases.

[13]  F. Cicuttini,et al.  Tackling obesity in knee osteoarthritis , 2013, Nature Reviews Rheumatology.

[14]  T. Dorner,et al.  Prevalence and status quo of osteoarthritis in Austria. Analysis of epidemiological and social determinants of health in a representative cross-sectional survey , 2013, Wiener Medizinische Wochenschrift.

[15]  A. Facchini,et al.  Increased serum vascular cell adhesion molecule (VCAM)-1 levels in patients with erosive hand osteoarthritis. , 2013, Rheumatology.

[16]  H. Abdala-Valencia,et al.  Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. , 2011, Antioxidants & redox signaling.

[17]  Leonid Kalichman,et al.  Association between vascular cell adhesion molecule 1 and radiographic hand osteoarthritis. , 2011, Clinical and experimental rheumatology.

[18]  Johanne Martel-Pelletier,et al.  Role of proinflammatory cytokines in the pathophysiology of osteoarthritis , 2011, Nature Reviews Rheumatology.

[19]  J. Willeit,et al.  Risk prediction for severe osteoarthritis , 2010, Annals of the rheumatic diseases.

[20]  S. Kiechl,et al.  Vascular cell adhesion molecule 1 as a predictor of severe osteoarthritis of the hip and knee joints. , 2009, Arthritis and rheumatism.

[21]  P. Nilsson,et al.  C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. , 2008, Osteoarthritis and cartilage.

[22]  B. Koes,et al.  Risk factors and prognostic factors of hip and knee osteoarthritis , 2007, Nature Clinical Practice Rheumatology.

[23]  F. Cappuccio,et al.  Cellular adhesion molecules and their relationship with measures of obesity and metabolic syndrome in a multiethnic population , 2006, International Journal of Obesity.

[24]  C. Helmick,et al.  Projections of US prevalence of arthritis and associated activity limitations. , 2006, Arthritis and rheumatism.

[25]  O. Wagner,et al.  Enalapril Does Not Alter Adhesion Molecule Levels in Human Endotoxemia , 2003, Shock.

[26]  A. Woolf,et al.  Burden of major musculoskeletal conditions. , 2003, Bulletin of the World Health Organization.

[27]  R. Marfella,et al.  Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women After Weight Loss Over One Year , 2002, Circulation.

[28]  J. von Kempis,et al.  Vascular cell adhesion molecule 1 (CD106) on primary human articular chondrocytes: functional regulation of expression by cytokines and comparison with intercellular adhesion molecule 1 (CD54) and very late activation antigen 2. , 1998, Arthritis and rheumatism.

[29]  E. Boerwinkle,et al.  Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. , 1997, Circulation.

[30]  A. Sakai.  Diclofenac inhibits endothelial cell adhesion molecule expression induced with lipopolysaccharide. , 1996, Life sciences.

[31]  P. Valent,et al.  Ibuprofen inhibits pyrogen-dependent expression of VCAM-1 and ICAM-1 on human endothelial cells. , 1996, Life sciences.

[32]  G. Firestein,et al.  Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. , 1992, Journal of immunology.

[33]  R. Tizard,et al.  Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes , 1989, Cell.